Your browser doesn't support javascript.
loading
Myricetin reverses epithelial-endothelial transition and inhibits vasculogenic mimicry and angiogenesis of hepatocellular carcinoma by directly targeting PAR1.
Wang, Ming; Ren, Shanfa; Bi, Zhun; Zhang, Liang; Cui, Mengqi; Sun, Ronghao; Bao, Jiali; Gao, Dandi; Yang, Bo; Li, Xiaoping; Li, Mingjiang; Xiao, Ting; Zhou, Hong-Gang; Yang, Cheng.
Afiliación
  • Wang M; State Key Laboratory of Medicinal Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, People's Republic of China.
  • Ren S; State Key Laboratory of Medicinal Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, People's Republic of China.
  • Bi Z; Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, People's Republic of China.
  • Zhang L; State Key Laboratory of Medicinal Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, People's Republic of China.
  • Cui M; Department of Thoracic Surgery, Tianjin First Central Hospital, Nankai University, Tianjin, People's Republic of China.
  • Sun R; State Key Laboratory of Medicinal Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, People's Republic of China.
  • Bao J; Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, People's Republic of China.
  • Gao D; State Key Laboratory of Medicinal Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, People's Republic of China.
  • Yang B; State Key Laboratory of Medicinal Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, People's Republic of China.
  • Li X; Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, People's Republic of China.
  • Li M; State Key Laboratory of Medicinal Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, People's Republic of China.
  • Xiao T; Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, People's Republic of China.
  • Zhou HG; Department of Thoracic Surgery, Tianjin First Central Hospital, Nankai University, Tianjin, People's Republic of China.
  • Yang C; Department of Thoracic Surgery, Tianjin First Central Hospital, Nankai University, Tianjin, People's Republic of China.
Phytother Res ; 36(4): 1807-1821, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35229382
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Revista: Phytother Res Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Revista: Phytother Res Año: 2022 Tipo del documento: Article